February 9, 2022
Enteral feeding kits pose a risk for strangulation in children, according to a safety alert from the US Food and Drug Administration (FDA). The safety alert […]
February 7, 2022
A new drug has become the first and only treatment for people with cold agglutinin disease (CAD) that is approved by the US Food and Drug […]
February 1, 2022
A new cell therapy will be available in Europe soon for the treatment of certain blood cancers. At its late January meeting, the Committee for Medicinal Products […]
January 29, 2022
The US Food and Drug Administration (FDA) today approved faricimab (Vabysmo, Genentech/Roche) to treat diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD). Compared with […]
January 28, 2022
The US Food and Drug Administration (FDA) has cleared the Omnipod 5 Automated Insulin Delivery System (Insulet Corporation), the third semi-automated closed-loop insulin delivery system in […]
January 27, 2022
A novel drug, the first in its class, has been approved by the US Food and Drug Administration (FDA) for use in the treatment of certain […]
January 22, 2022
The US Food and Drug Administration (FDA) today approved risankizumab-rzaa (Skyrizi) for a second indication — treating adults with active psoriatic arthritis (PsA) — making it […]
January 20, 2022
The Swedish medical technology company Getinge is issuing a recall of the Vaporizer Sevoflurane Maquet Filling for Flow Family Anesthesia Systems due to risk of chemical […]
January 11, 2022
Medicare intends to limit coverage of the controversial Alzheimer’s drug, aducanumab (Aduhelm, Biogen) via a special program intended to help assess how well this exorbitantly expensive medication […]